A protein C blood test measures one of the body’s own brakes on clotting. Protein C is a natural anticoagulant made in the liver, and when it is low, blood can clot more readily than it should. That is why the test usually appears on a lab order after an unexplained clot, a clot at a young age, or a family history of clotting problems.
In this article you’ll learn what the test actually measures, how activity testing differs from antigen testing, how to read the percentages on your report, what pushes protein C levels down, and why timing your blood draw matters more than most people expect. You’ll also find what recent research says about who genuinely benefits from testing.
What a protein C blood test measures
Clotting is a controlled chain reaction. One factor activates the next, and within seconds a mesh of fibrin seals a damaged vessel. Left unchecked, that same chain reaction would keep going and block healthy vessels, so the body runs a set of counterweights alongside it. Protein C is one of the most important.
Protein C circulates in an inactive form until thrombin, the enzyme that finishes clot formation, binds to a receptor on the vessel wall called thrombomodulin. That pairing flips thrombin from a clot builder into a protein C activator. Activated protein C then switches off two accelerator factors, factor Va and factor VIIIa, slowing the cascade before it overshoots. If you want the wider picture of how these steps fit together, review the full sequence in our coagulation test results guide.
Two details explain most of what shows up on a lab report. First, protein C needs vitamin K to be built correctly, which ties it directly to liver function and to warfarin therapy. Second, protein C does not work alone: it needs a helper molecule to be fully effective, and clinicians almost always order both together. That partner is covered in our protein S test results guide.
Activity testing versus antigen testing
Laboratories can answer two different questions about protein C, and the distinction matters when you read your report.
Protein C activity
An activity assay, sometimes labeled a functional assay, asks how well your protein C works. The lab adds a snake venom extract or a similar activator to your plasma and measures how much clotting slows down. This is the standard first-line test because it catches both problems at once: too little protein C, and protein C that is present but defective.
Protein C antigen
An antigen assay, or immunologic assay, simply counts how many protein C molecules are present, regardless of whether they function. It is normally added only when activity comes back low, because the combination sorts a deficiency into one of two categories.
| Result pattern | What it suggests | What clinicians call it |
|---|---|---|
| Activity low, antigen low | The body makes too few protein C molecules, and the ones present work normally | Type I (quantitative) deficiency |
| Activity low, antigen normal | Enough molecules are made, but they do not function properly | Type II (qualitative) deficiency |
| Activity normal, antigen normal | No evidence of protein C deficiency on this sample | Normal result |
| Activity borderline, antigen normal | Often a timing or medication effect rather than true deficiency | Requires a repeat sample |
Because a single low reading rarely settles anything, most laboratories and specialists ask for a confirming sample weeks or months later, drawn under conditions that do not distort the result.
How to read your protein C results
Protein C is reported as a percentage of normal adult activity rather than a concentration. A value of 100% means your plasma slows clotting about as much as pooled plasma from healthy adults. Reference ranges differ slightly between laboratories, so always compare your number against the range printed on your own report.
| Result band | How it is usually described | Common next step |
|---|---|---|
| Roughly 70% to 140% | Within the expected adult range | No further protein C work-up on this marker |
| Just below the lower limit | Borderline, frequently transient | Repeat when off anticoagulants and away from an acute clot |
| Around 20% to 60% | Mild to moderate reduction, the pattern seen in inherited heterozygous deficiency | Confirm on a second sample, then assess personal and family history |
| Under about 20% | Severe reduction, rare outside newborns and acute illness | Urgent specialist assessment |
| Above the upper limit | High protein C, not linked to a known disease | No action required |
High protein C is worth a sentence of reassurance, because it is a common source of worry. There is no recognized condition caused by too much protein C, and a high value is not treated. Laboratories report it because the assay measures in both directions, not because the number carries risk.
One structural point often missed: protein C sits in the same vitamin K-dependent family as the factors measured by clotting time tests, so its result is best read next to them. Compare it against the timing measures explained in our prothrombin time results guide, and check how anticoagulant intensity is standardized in our explanation of the international normalized ratio.
What lowers protein C levels
A low result has two very different explanations, and separating them drives everything that follows. Inherited deficiency is permanent and runs in families. Acquired deficiency is a temporary consequence of something else happening in the body, and it resolves when that cause resolves.
| Cause | Inherited or acquired | Why protein C falls | Does it resolve? |
|---|---|---|---|
| PROC gene variant | Inherited | The gene that codes for protein C carries a change that reduces output or function | No, it is lifelong |
| Warfarin therapy | Acquired | Warfarin blocks vitamin K, and protein C is vitamin K-dependent | Yes, once the drug is stopped |
| Active blood clot | Acquired | Protein C is consumed while the body responds to the clot | Yes, over weeks after the event |
| Liver disease | Acquired | The liver makes protein C, so damaged liver tissue makes less | Improves if liver function improves |
| Severe infection or sepsis | Acquired | Widespread clotting activation uses protein C faster than it is made | Yes, with recovery |
| Vitamin K deficiency | Acquired | Without vitamin K the molecule cannot be assembled correctly | Yes, once stores are restored |
| Newborn period | Physiologic | Levels are naturally low at birth and rise through infancy | Yes, with normal maturation |
The warfarin point deserves emphasis because it is the single most common reason a protein C result is misread. Warfarin lowers protein C rapidly, so a test drawn during treatment can look like inherited deficiency when nothing inherited is present. Vitamin K status underpins the same pathway, which our vitamin K blood level guide explains in more detail.
Acute clotting is the second common distortion. If blood is drawn while a clot is still active, protein C is being consumed and the number drops for reasons that have nothing to do with genetics. Clot activity itself is usually tracked with a different marker, described in our D-dimer test results guide.
When protein C testing changes something, and when it does not
This is where guidance has shifted noticeably. For years, anyone with a clot might be offered a broad thrombophilia panel. Current specialist guidance is far more selective, because a result only earns its place if it changes a decision.
Use the questions below as a practical filter before testing, and bring them to the appointment rather than treating them as a substitute for one.
Testing is more likely to help when
- A close relative has a confirmed protein C, protein S, or antithrombin deficiency, and you are weighing estrogen-containing contraception or pregnancy planning.
- A clot appeared in an unusual location, such as the veins draining the brain or the abdomen.
- A first clot happened before age 50 with no surgery, injury, immobility, or hormone trigger to explain it.
- Anticoagulation would otherwise be stopped, and the result would genuinely tip that decision.
Testing rarely helps when
- A clot followed an obvious, temporary trigger such as major surgery or a long period of immobility.
- You are currently taking warfarin or a direct oral anticoagulant, or you are within weeks of an acute clot.
- You are screening a healthy population before starting combined oral contraceptives without any family history.
- The plan for anticoagulation is already settled on clinical grounds alone.
Protein C is one member of a small family of natural anticoagulants, and a specialist usually interprets it alongside the others rather than in isolation. The closest relative is explained in our antithrombin III test results guide. Understanding the condition the whole panel is meant to anticipate helps too, and our guide to deep vein thrombosis symptoms and treatment covers the warning signs worth knowing.
Special situations that change interpretation
Newborns and infants
Babies are born with protein C activity far below adult values, and levels climb gradually through the first months and years of life. An adult reference range applied to a newborn will suggest deficiency where none exists. Pediatric hematologists use age-specific ranges for exactly this reason. Severe inherited deficiency does present in the newborn period, but it announces itself dramatically rather than quietly, with widespread skin and vessel clotting.
Pregnancy and hormonal therapy
Pregnancy shifts the clotting balance toward clot formation, and estrogen-containing contraception does something similar. Protein C activity itself changes less than other markers, but the surrounding context changes a great deal, so results from pregnancy are interpreted with caution and often repeated afterward. Other clot-related markers rise sharply in pregnancy, including the one described in our fibrinogen blood level guide.
People already on anticoagulants
Warfarin makes protein C testing unreliable, and direct oral anticoagulants can interfere with the laboratory chemistry of activity assays in either direction. Specialists usually schedule testing after a planned break from treatment, supervised so that clot risk is not raised in the process. Never stop an anticoagulant on your own to get a cleaner laboratory number.
How the test is done and how to prepare
The draw itself is ordinary: a standard venous sample, usually from the arm, collected into a tube containing an anticoagulant that keeps the plasma testable. No fasting is required for protein C alone, though other tests ordered on the same day may have their own instructions.
Preparation matters less in what you do beforehand and more in when the sample is taken. Three timing rules cover most of it.
- Wait until at least several weeks have passed since an acute clot, so consumption has stopped skewing the result.
- Test away from warfarin, following a schedule your clinician sets rather than one you improvise.
- Confirm any abnormal result on a second sample before treating it as a diagnosis.
Tell the laboratory about every medication you take, including over-the-counter supplements. Vitamin K supplements, recent antibiotic courses, and hormonal treatments can all influence the interpretation. If your work-up includes a broader look at vessel health, our homocysteine blood level guide covers another marker frequently ordered alongside clotting studies.
Latest scientific advances
Research from the last three years has changed the conversation about protein C less in how the test is run and more in who should have it, and what a low result really predicts. Here is what the recent literature reports, in plain terms.
Guidelines narrowed who should be tested
An expert panel convened by the American Society of Hematology reviewed the evidence and issued detailed recommendations on thrombophilia testing, which is the umbrella term for tests looking for an inherited tendency to clot. Their conclusion was strikingly conservative: they advised against testing the general population before starting combined oral contraceptives, and they supported testing only in specific situations, such as a family history of protein C, protein S, or antithrombin deficiency, or clots in unusual locations. The panel was also candid that confidence in much of the underlying evidence is low.
What this means for you: if your clinician does not order a protein C test after a clot, that is often a considered decision rather than an oversight. The question that guides testing is whether the answer would change your treatment.
A large variant database mapped how deficiency actually behaves
A 2025 study assembled thousands of published cases of inherited protein C deficiency into a single searchable database, and then looked for patterns. Two findings stand out for patients. First, people who inherited a change from both parents behave very differently from people who inherited one, with earlier and more severe presentations in the first group. Second, in people carrying a single inherited change, protein C activity alone did not predict when problems would appear, which suggests that other risk factors usually need to be present alongside it for a clot to occur.
What this means for you: carrying a protein C variant is a risk factor, not a forecast. It raises the importance of managing the things you can change, such as movement during long travel, and of getting proper preventive care around surgery.
Attention widened from vein clots to artery clots
A 2024 editorial reviewed reports linking protein C deficiency not only to the vein clots it is classically associated with, but also to arterial events such as heart attack and ischemic stroke. The authors were careful to frame this as an emerging association drawn from case reports rather than established cause, and they called for more systematic study.
What this means for you: this is preliminary and needs confirmation. It is not a reason to expect arterial disease if you have low protein C, but it is a reason for specialists to look at the whole cardiovascular picture rather than veins alone.
Interpretation, not the assay, remains the hard part
A 2025 review of thrombophilia testing in venous thromboembolism made a practical point that laboratories have long recognized: which tests to order, and when to draw the sample, vary widely between centers, and both the testing and the interpretation call for specific expertise. The review concluded that the role of these results in guiding how long someone stays on anticoagulation is still being worked out.
What this means for you: a protein C number is not self-explanatory. Its meaning depends on when it was drawn, what medications you were taking, and what else was happening in your body at the time.
Glossary of key terms
| Term | Definition |
|---|---|
| Protein C | A natural anticoagulant made in the liver that slows blood clotting by switching off two clotting accelerators. |
| Activated protein C | The working form of protein C, switched on when thrombin binds to thrombomodulin on the vessel wall. |
| Anticoagulant | Anything that slows clot formation. The body makes its own; medications add to that effect. |
| Thrombophilia | An increased tendency to form blood clots, either inherited or acquired. |
| Thrombomodulin | A receptor on the inner lining of blood vessels that converts thrombin into an activator of protein C. |
| Activity assay | A laboratory test measuring how well a protein works, rather than how much of it is present. |
| Antigen assay | A laboratory test counting how many molecules of a protein are present, whether or not they function. |
| Venous thromboembolism (VTE) | The umbrella term covering deep vein thrombosis and pulmonary embolism, a clot that travels to the lungs. |
| Heterozygous | Carrying an inherited change on one of the two copies of a gene. |
| PROC gene | The gene that carries the instructions for making protein C. Changes in it cause inherited deficiency. |
Frequently asked questions
Is a low protein C result the same as having a clotting disorder?
Not on its own. A single low value most often reflects timing or medication rather than an inherited condition. Warfarin, an active clot, liver problems, and severe infection all lower protein C temporarily. A diagnosis of inherited deficiency requires a confirmed low result on a second sample, drawn under clean conditions, and it is interpreted alongside your personal and family history rather than as a standalone number.
What causes high protein C in blood?
High protein C has no recognized disease behind it and no established clinical consequence. Values can drift above the reference range for reasons as ordinary as normal biological variation between individuals or laboratory method differences. Because there is no condition of protein C excess, a high result is not treated and generally does not need repeating. If it appears alongside other unexpected findings, your clinician will focus on those instead.
Does protein C need to be tested with protein S?
They are almost always ordered together, because they work as a pair. Protein S acts as a cofactor that makes activated protein C substantially more effective, so a deficiency in either one produces a broadly similar tendency toward clotting. Testing both, usually alongside antithrombin, gives a fuller picture of the body’s natural braking system than any single result can.
Can protein C levels be improved through diet or lifestyle?
There is no diet or supplement that raises protein C in a way that has been shown to reduce clot risk, and inherited deficiency cannot be corrected by lifestyle. What lifestyle does influence is your overall clotting risk: staying mobile on long journeys, maintaining a healthy weight, and not smoking all matter. If a deficiency is confirmed, prevention is built around specific higher-risk moments such as surgery, immobility, and pregnancy.
How long after a blood clot should I wait before testing?
Specialists generally advise waiting until well after the acute phase has settled, and until anticoagulant treatment can be paused safely under supervision. During an active clot, protein C is being used up, so an early sample tends to read low regardless of your baseline. The exact interval depends on your treatment plan and your clot history, which is why the timing is set by the clinician managing your care.
Will a protein C deficiency be passed to my children?
Inherited protein C deficiency follows a straightforward pattern: each child of a parent carrying a single altered copy has a one in two chance of inheriting that copy. Most people who inherit one copy never develop a clot, and many are identified only through family testing. Inheriting an altered copy from both parents is rare and far more serious, usually presenting in the newborn period. Genetic counseling is the right setting for these questions.
Sources
- MedlinePlus, National Library of Medicine — Protein C and Protein S Tests — MedlinePlus Medical Test, 2025 — medlineplus.gov
- Centers for Disease Control and Prevention — About Blood Clots — CDC Venous Thromboembolism, 2025 — cdc.gov
- National Heart, Lung, and Blood Institute — Venous Thromboembolism — NHLBI Health Topics, 2025 — nhlbi.nih.gov
- Mayo Clinic — Deep Vein Thrombosis (DVT): Symptoms and Causes — Mayo Clinic Diseases and Conditions, 2025 — mayoclinic.org
- Middeldorp S, Nieuwlaat R, Baumann Kreuziger L, et al. — American Society of Hematology 2023 Guidelines for Management of Venous Thromboembolism: Thrombophilia Testing — Blood Advances, 2023 — doi.org/10.1182/bloodadvances.2023010177
- Zhang S, Dong S, Hou Z, et al. — Novel Insights into Inherited Protein C Deficiency from an Interactive PROC Variant Database — Journal of Thrombosis and Haemostasis, 2025 — doi.org/10.1016/j.jtha.2025.07.030
- Vrotniakaite-Bajerciene K, Angelillo-Scherrer A, Castellucci LA — Thrombophilia Testing in Venous Thromboembolism — Medical Clinics of North America, 2025 — doi.org/10.1016/j.mcna.2025.01.008
- Zhang N, Sun DK, Tian X, Zheng XY, Liu T — Protein C Deficiency with Venous and Arterial Thromboembolic Events — World Journal of Clinical Cases, 2024 — doi.org/10.12998/wjcc.v12.i12.2000
Further reading
- Check the cells that start every clot by reading our platelet count test results guide.
- Explore the second clotting time measured on most coagulation panels with our partial thromboplastin time results guide.
- Assess what platelet size adds to a clotting work-up by reading our mean platelet volume results guide.
- Compare protein C with the other major natural anticoagulant using our antithrombin activity lab test guide.
- Decode another platelet index that often appears beside your clotting results with our platelet distribution width lab test guide.
Understand your lab results with BloodSense
Get your results interpreted in minutes
A protein C percentage on its own tells you very little. Its meaning comes from the company it keeps: protein S, antithrombin, prothrombin time, and the clot marker D-dimer all shape how a single number should be read. BloodSense turns that cluster of values into plain language you can bring to your next appointment. It helps you understand what your report says, and it never replaces the clinician who decides what to do about it.
